Skip to main content
SpringerLink
Log in

Diagnosis and Management of Sickle Cell Disorders

  • Protocol
  • First Online:
Anticoagulants, Antiplatelets, and Thrombolytics

Part of the book series: Methods in Molecular Biology ((MIMB,volume 663))

Abstract

Sickle cell disease (SCD) is a wide-spread inherited hemolytic anemia that is due to a point mutation leading to a valine/glutamic acid substitution in the β-globin chain, causing a spectrum of clinical manifestations in addition to hemolysis and anemia. Acute painful crisis is a common sequela that can cause significant morbidity and negatively impact the patient’s quality of life. Remarkable improvements in our understanding of the pathogenesis of this clinical syndrome and the role of cell adhesion, inflammation, and coagulation in acute painful crisis have led to changes in the management of pain. Due to the endemic nature of SCD in various parts of the Middle East, a group of physicians and scientists from the United States and Middle East recently met to draw up a set of suggested guidelines for the management of acute painful crisis that are reflective of local and international experience. This chapter brings together a detailed etiology, pathophysiology, and clinical presentation of SCD, including the differential diagnoses of pain associated with the disease, with evidence-based recommendations for pain management and the potential impact of low-molecular weight heparin (LMWH), from the perspective of physicians and scientists with long-term experience in the management of a large number of SCD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jeremiah, Z.A. (2006) Abnormal haemoglobin variants, ABO and Rh blood groups among student of African descent in Port Harcourt, Nigeria Afr Health Sci 6, 177–81.

    PubMed  Google Scholar 

  2. Hiran, S. (2005) Multiorgan dysfunction syndrome in sickle cell disease J Assoc Physic India 53, 19–22.

    Google Scholar 

  3. Alhamdan, N.A., Almazrou, Y.Y., Alswaidi, F.M., and Choudhry, A.J. (2007) Premarital screening for thalassemia and sickle cell disease in Saudi Arabia Genet Med 9, 372–7.

    Article  PubMed  Google Scholar 

  4. Al-Riyami, A., and Ebrahim, G.J. (2003) Genetic blood disorders survey in the Sultanate of Oman J Trop Pediatr 49(Suppl 1), i1–20.

    PubMed  Google Scholar 

  5. Mohammed, A.M., Al-Hilli, F., Nadkarni, K.V., Bhagwat, G.P., and Bapat, J.P. (1992) Hemoglobinopathies and glucose-6-phosphate dehydrogenase deficiency in hospital births in Bahrain Ann Saudi Med 12, 536–9.

    PubMed  CAS  Google Scholar 

  6. el-Hazmi, M.A., and Warsy, A.S. (1999) Appraisal of sickle-cell and thalassaemia genes in Saudi Arabia East Mediterr Health J 5, 1147–53.

    PubMed  CAS  Google Scholar 

  7. El-Hazmi, M.A., and Warsy, A.S. (1994) The frequency of glucose-6-phosphate dehydrogenase phenotypes and sickle cell genes in Al-Qatif oasis Ann Saudi Med 14, 491–4.

    PubMed  CAS  Google Scholar 

  8. Qari, M.H., Aljaouni, S.K., Alardawi, M.S., Fatani, H., Alsayes, F.M., Zografos, P., Alsaigh, M., Alalfi, A., Alamin, M., Gadi, A., and Mousa, S.A. (2007) Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial Thromb Haemost 98, 392–6.

    PubMed  CAS  Google Scholar 

  9. Aslan, M., and Freeman, B.A. (2007) Redox-dependent impairment of vascular function in sickle cell disease Free Radic Biol Med 43, 1469–83.

    Article  PubMed  CAS  Google Scholar 

  10. Hebbel, R.P., Osarogiagbon, R., and Kaul, D. (2004) The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy Microcirculation 11, 129–51.

    Article  PubMed  CAS  Google Scholar 

  11. Mehta, S.R., Afenyi-Annan, A., Byrns, P.J., and Lottenberg, R. (2006) Opportunities to improve outcomes in sickle cell disease Am Fam Physician 74, 303–10.

    PubMed  Google Scholar 

  12. Hebbel, R.P., Boogaerts, M.A., Eaton, J.W., and Steinberg, M.H. (1980) Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity N Engl J Med 302, 992–5.

    Article  PubMed  CAS  Google Scholar 

  13. Grigg, A.P. (2001) Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+thalassemia Blood 97, 3998–9.

    Article  PubMed  CAS  Google Scholar 

  14. Ataga, K.I., and Key, N.S. (2007) Hypercoagulability in sickle cell disease: new approaches to an old problem Hematol Am Soc Hematol Educ Program 2007, 91–6.

    Google Scholar 

  15. Inwald, D.P., Kirkham, F.J., Peters, M.J., Lane, R., Wade, A., Evans, J.P., and Klein, N.J. (2000) Platelet and leucocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia Br J Haematol 111, 474–81.

    Article  PubMed  CAS  Google Scholar 

  16. Tomer, A., Harker, L.A., Kasey, S., and Eckman, J.R. (2001) Thrombogenesis in sickle cell disease J Lab Clin Med 137, 398–407.

    Article  PubMed  CAS  Google Scholar 

  17. Key, N.S., Slungaard, A., Dandelet, L., Nelson, S.C., Moertel, C., Styles, L.A., Kuypers, F.A., and Bach, R.R. (1998) Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease Blood 91, 4216–23.

    PubMed  CAS  Google Scholar 

  18. Ataga, K.I., Moore, C.G., Hillery, C.A., Jones, S., Whinna, H.C., Strayhorn, D., Sohier, C., Hinderliter, A., Parise, L.V., and Orringer, E.P. (2008) Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension Haematologica 93, 20–6.

    Article  PubMed  CAS  Google Scholar 

  19. Etienne-Julan, M., Belloy, M.S., Decastel, M., Dougaparsad, S., Ravion, S., and Hardy-Dessources, M.D. (2004) Childhood sickle cell crises: clinical severity, inflammatory markers and the role of interleukin-8 Haematologica 89, 863–4.

    PubMed  CAS  Google Scholar 

  20. Ballas, S.K. (2007) Current issues in sickle cell pain and its management Hematol Am Soc Hematol Educ Prog 2007, 97–105.

    Google Scholar 

  21. Frenette, P.S., and Atweh, G.F. (2007) Sickle cell disease: old discoveries, new concepts, and future promise J Clin Invest 117, 850–8.

    Article  PubMed  CAS  Google Scholar 

  22. Al-Absi, I.K., Al-Subaie, A.M., Ameen, G., Mahdi, N., Mohammad, A.M., Fawaz, N.A., and Almawi, W.Y. (2006) Association of the methylenetetrahydrofolate reductase A1298C but not the C677T single nucleotide polymorphism with sickle cell disease in Bahrain Hemoglobin 30, 449–53.

    Article  PubMed  CAS  Google Scholar 

  23. Mid-Atlantic Regional Human Genetics Network (MARHGN). Sickle cell disease in children and adolescents: diagnosis, guidelines for comperhensive care, and protocols for management of acute and chronic complications. In: Mid-Atlantic Sickle Cell Disease Consortium (MASCC) Practice Guidelines Workgroup;2002.

    Google Scholar 

  24. Shapiro, B.S. (1989) The management of pain in sickle cell disease Pediatr Clin North Am 36, 1029–45.

    PubMed  CAS  Google Scholar 

  25. Platt, O.S., Thorington, B.D., Brambilla, D.J., Milner, P.F., Rosse, W.F., Vichinsky, E., and Kinney, T.R. (1991) Pain in sickle cell disease. Rates and risk factors N Engl J Med 325, 11–6.

    Article  PubMed  CAS  Google Scholar 

  26. Platt, O.S., Brambilla, D.J., Rosse, W.F., Milner, P.F., Castro, O., Steinberg, M.H., and Klug, P.P. (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death N Engl J Med 330, 1639–44.

    Article  PubMed  CAS  Google Scholar 

  27. Barakat, L.P., Patterson, C.A., Daniel, L.C., and Dampier, C. (2008) Quality of life among adolescents with sickle cell disease: mediation of pain by internalizing symptoms and parenting stress Health Qual Life Outcomes 6, 60.

    Article  PubMed  Google Scholar 

  28. Hassell, K.L., Eckman, J.R., and Lane, P.A. (1994) Acute multiorgan failure syndrome: a potentially catastrophic complication of severe sickle cell pain episodes Am J Med 96, 155–62.

    Article  PubMed  CAS  Google Scholar 

  29. Robieux, I.C., Kellner, J.D., Coppes, M.J., Shaw, D., Brown, E., Good, C., O’Brodovich, H., Manson, D., Olivieri, N.F., Zipursky, A., et al. (1992) Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation Pediatr Hematol Oncol 9, 317–26.

    Article  PubMed  CAS  Google Scholar 

  30. Yale, S.H., Nagib, N., and Guthrie, T. (2000) Approach to the vaso-occlusive crisis in adults with sickle cell disease Am Fam Physic 61, 1349–56, 63–4.

    CAS  Google Scholar 

  31. Benjamin, L., Dampier, C., Jacox, A., Odesina, V., Pheonix, D., Shapiro, B., Strafford, M., and Treadwell, M. Guideline for the Management of Acute and Chronic Pain in Sickle-Cell Disease. American Pain Society;1999.

    Google Scholar 

  32. American Academy of Pediatrics, S.o.H.O. C.o.G.A.A.o. (2002) Health supervision for children with sickle cell disease Pediatrics 109, 526–35.

    Google Scholar 

  33. Preboth, M. (2000) Management of pain in sickle cell disease Am Fam Physician 61, 1544, 9–50.

    PubMed  CAS  Google Scholar 

  34. Reid, C., Charache, S., and Lubin, B.e. Management of Therapy of Sickle Cell Disease, 3rd edition. Bethesda, MD: National Institutes of Health;1995.

    Google Scholar 

  35. Jacobson, S.J., Kopecky, E.A., Joshi, P., and Babul, N. (1997) Randomised trial of oral morphine for painful episodes of sickle-cell disease in children Lancet 350, 1358–61.

    Article  PubMed  CAS  Google Scholar 

  36. Zempsky, W.T., Loiselle, K.A., McKay, K., Blake, G.L., Hagstrom, J.N., Schechter, N.L., and Kain, Z.N. (2008) Retrospective evaluation of pain assessment and treatment for acute vasoocclusive episodes in children with sickle cell disease Pediatr Blood Cancer 51, 265–8.

    Article  PubMed  Google Scholar 

  37. Panel, S.C.D.G. Sickle Cell Disease: Screening, Diagnosis, Management and Counseling in Newborns and Infants. Rockville, MD: AHCPR;1993.

    Google Scholar 

  38. Field, J.J., Knight-Perry, J.E., and Debaun, M.R. (2009) Acute pain in children and adults with sickle cell disease: management in the absence of evidence-based guidelines Current Opin Hematol 16, 173–8.

    Article  Google Scholar 

  39. Morrissey, L.K., Shea, J.O., Kalish, L.A., Weiner, D.L., Branowicki, P., and Heeney, M.M. (2009) Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain Pediatr Blood Cancer 52, 369–72.

    Article  PubMed  Google Scholar 

  40. Niscola, P., Sorrentino, F., Scaramucci, L., de Fabritiis, P., and Cianciulli, P. (2009) Pain syndromes in sickle cell disease: an update Pain Med(Malden, Mass 10), 470–80.

    Article  Google Scholar 

  41. Pack-Mabien, A., and Haynes, J., Jr. (2009) A primary care provider’s guide to preventive and acute care management of adults and children with sickle cell disease J Am Acad Nurse Practition 21, 250–7.

    Article  Google Scholar 

  42. Richard, R.E. (2009) The management of sickle cell pain Curr Pain Headache Rep 13, 295–7.

    Article  PubMed  Google Scholar 

  43. Meremikwu, M.M. (2009) Sickle cell disease Clin Evid (Online) 2009, 2402.

    Google Scholar 

  44. Chaplin, H., Jr., Monroe, M.C., Malecek, A.C., Morgan, L.K., Michael, J., and Murphy, W.A. (1989) Preliminary trial of minidose heparin prophylaxis for painful sickle cell crises East Afr Med J 66, 574–84.

    PubMed  Google Scholar 

  45. Embury, S.H., Matsui, N.M., Ramanujam, S., Mayadas, T.N., Noguchi, C.T., Diwan, B.A., Mohandas, N., and Cheung, A.T. (2004) The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo Blood 104, 3378–85.

    Article  PubMed  CAS  Google Scholar 

  46. Kirkham, F.J., Lerner, N.B., Noetzel, M., DeBaun, M.R., Datta, A.K., Rees, D.C., and Adams, R.J. (2006) Trials in sickle cell disease Pediatr Neurol 34, 450–8.

    Article  PubMed  Google Scholar 

  47. Matsui, N.M., Varki, A., and Embury, S.H. (2002) Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin Blood 100, 3790–6.

    Article  PubMed  CAS  Google Scholar 

  48. Mousa, S.A. (2005) Elevation of plasma von Willebrand factor and tumor necrosis factor-a in obese subjects and their reduction by the low molecular weight heparin tinzaparin Int Angiol 24, 278–81.

    PubMed  CAS  Google Scholar 

  49. Mousa, S.A. (2005) Effect of low molecular weight heparin and different heparin molecular weight fractions on the activity of the matrix-degrading enzyme aggrecanase: structure-function relationship J Cell Biochem 95, 95–8.

    Article  PubMed  CAS  Google Scholar 

  50. Mousa, S.A. (2006) Inhibitory effect of C-reactive protein on the release of tissue factor pathway inhibitor from human endothelial cells: reversal by low molecular weight heparin Int Angiol 25, 10–3.

    PubMed  CAS  Google Scholar 

  51. Mousa, S.A., Bozarth, J., and Barrett, J.S. (2003) Pharmacodynamic properties of the low molecular weight heparin, tinzaparin: effect of molecular weight distribution on plasma tissue factor pathway inhibitor in healthy human subjects J Clin Pharmacol 43, 727–34.

    PubMed  CAS  Google Scholar 

  52. Mousa, S.A., and Johansen, K. (2005) Pharmacodynamic effects of low molecular weight heparin in obese subjects following subcutaneous administration of 75 IU/kg on plasma tissue factor pathway inhibitor and nitric oxide Int Angiol 24, 40–2.

    PubMed  CAS  Google Scholar 

  53. Stevenson, J.L., Choi, S.H., and Varki, A. (2005) Differential metastasis inhibition by clinically relevant levels of heparins–correlation with selectin inhibition, not antithrombotic activity Clin Cancer Res 11, 7003–11.

    Article  PubMed  CAS  Google Scholar 

  54. Mousa, S.A. (2002) The low molecular weight heparin, tinzaparin, in thrombosis and beyond Cardiovasc Drug Rev 20, 199–216.

    Article  PubMed  CAS  Google Scholar 

  55. Puskas, A., Balogh, Z., Hadadi, L., Imre, M., Orban, E., Kosa, K., Brassai, Z., and Mousa, S.A. (2007) Spontaneous recanalization in deep venous thrombosis: a prospective duplex ultrasound study Int Angiol 26, 53–63.

    PubMed  CAS  Google Scholar 

  56. Bellet, P.S., Kalinyak, K.A., Shukla, R., Gelfand, M.J., and Rucknagel, D.L. (1995) Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases N Engl J Med 333, 699–703.

    Article  PubMed  CAS  Google Scholar 

  57. Vichinsky, E.P., Neumayr, L.D., Earles, A.N., Williams, R., Lennette, E.T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C., and Manci, E.A. (2000) Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group N Engl J Med 342, 1855–65.

    Article  PubMed  CAS  Google Scholar 

  58. Greenberg, J., Ohene-Frempong, K., Halus, J., Way, C., and Schwartz, E. (1983) Trial of low doses of aspirin as prophylaxis in sickle cell disease J Pediatr 102, 781–4.

    Article  PubMed  CAS  Google Scholar 

  59. Osamo, N.O., Photiades, D.P., and Famodu, A.A. (1981) Therapeutic effect of aspirin in sickle cell anaemia Acta Haematol 66, 102–7.

    Article  PubMed  CAS  Google Scholar 

  60. Quinn, C.T., and Buchanan, G.R. (1999) The acute chest syndrome of sickle cell disease J Pediatr 135, 416–22.

    Article  PubMed  CAS  Google Scholar 

  61. Salvaggio, J.E., Arnold, C.A., and Banov, C.H. (1963) Long-term anti-coagulation in sickle-cell disease. A clinical study N Engl J Med 269, 182–6.

    Article  PubMed  CAS  Google Scholar 

  62. Wolters, H.J., ten Cate, H., Thomas, L.L., Brandjes, D.P., van der Ende, A., van der Heiden, Y., and Statius van Eps, L.W. (1995) Low-intensity oral anticoagulation in sickle-cell disease reverses the prethrombotic state: promises for treatment? Br J Haematol 90, 715–7.

    Article  PubMed  CAS  Google Scholar 

  63. Zago, M.A., Costa, F.F., Ismael, S.J., Tone, L.G., and Bottura, C. (1984) Treatment of sickle cell diseases with aspirin Acta Haematol 72, 61–4.

    Article  PubMed  CAS  Google Scholar 

  64. Ballas, S.K. (1990) Treatment of pain in adults with sickle cell disease Am J Hematol 34, 49–54.

    Article  PubMed  CAS  Google Scholar 

  65. Anie, K.A., and Green, J. (2002) Psychological therapies for sickle cell disease and pain Cochrane Database Syst Rev CD001916.

    Google Scholar 

  66. Bodhise, P.B., Dejoie, M., Brandon, Z., Simpkins, S., and Ballas, S.K. (2004) Non-pharmacologic management of sickle cell pain Hematology 9, 235–7.

    Article  PubMed  Google Scholar 

  67. Thomas, V.J., Gruen, R., and Shu, S. (2001) Cognitive-behavioural therapy for the management of sickle cell disease pain: identification and assessment of costs Ethn Health 6, 59–67.

    Article  PubMed  CAS  Google Scholar 

  68. Serjeant, G.R. (1997) Sickle-cell disease Lancet 350, 725–30.

    Article  PubMed  CAS  Google Scholar 

  69. Sun, P.M., Wilburn, W., Raynor, B.D., and Jamieson, D. (2001) Sickle cell disease in pregnancy: twenty years of experience at Grady Memorial Hospital, Atlanta, Georgia Am J Obstet Gynecol 184, 1127–30.

    Article  PubMed  CAS  Google Scholar 

  70. Villers, M.S., Jamison, M.G., De Castro, L.M., and James, A.H. (2008) Morbidity associated with sickle cell disease in pregnancy Am J Obstet Gynecol 199, 125 e1–5.

    PubMed  Google Scholar 

  71. Smith, J.A., Espeland, M., Bellevue, R., Bonds, D., Brown, A.K., and Koshy, M. (1996) Pregnancy in sickle cell disease: experience of the cooperative study of sickle cell disease Obstet Gynecol 87, 199–204.

    Article  PubMed  CAS  Google Scholar 

  72. Rees, D.C., Olujohungbe, A.D., Parker, N.E., Stephens, A.D., Telfer, P., and Wright, J. (2003) Guidelines for the management of the acute painful crisis in sickle cell disease Br J Haematol 120, 744–52.

    Article  PubMed  Google Scholar 

  73. Koshy, M., Burd, L., Wallace, D., Moawad, A., and Baron, J. (1988) Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study N Engl J Med 319, 1447–52.

    Article  PubMed  CAS  Google Scholar 

  74. Faron, G., Corbisier, C., Tecco, L., and Vokaer, A. (2001) First sickle cell crisis triggered by induction of labor in a primigravida Eur J Obstet Gynecol Reprod Biol 94, 304–6.

    Article  PubMed  CAS  Google Scholar 

  75. Sanson, B.J., Lensing, A.W., Prins, M.H., Ginsberg, J.S., Barkagan, Z.S., Lavenne-Pardonge, E., Brenner, B., Dulitzky, M., Nielsen, J.D., Boda, Z., Turi, S., Mac Gillavry, M.R., Hamulyak, K., Theunissen, I.M., Hunt, B.J., and Buller, H.R. (1999) Safety of low-molecular-weight heparin in pregnancy: a systematic review Thromb Haemost 81, 668–72.

    PubMed  CAS  Google Scholar 

  76. Bates, S.M., Greer, I.A., Hirsh, J., and Ginsberg, J.S. (2004) Use of antithrombotic agents during pregnancy: the seventh ACCP conference on antithrombotic and thrombolytic therapy Chest 126, 627–44S.

    Article  Google Scholar 

  77. Ginsberg, J.S., Greer, I., and Hirsh, J. (2001) Use of antithrombotic agents during pregnancy Chest 119, 122–31S.

    Article  Google Scholar 

  78. Greer, I.A. (2005) Venous thromboembolism and anticoagulant therapy in pregnancy Gend Med 2(Suppl A), S10–7.

    Article  PubMed  Google Scholar 

  79. Villa-Forte Gomes, M.P. (2009) Venous thromboembolism in pregnancy Curr Treatment Opt Cardiovasc Med 11, 104–13.

    Article  Google Scholar 

  80. Smith, M.P., Norris, L.A., Steer, P.J., Savidge, G.F., and Bonnar, J. (2004) Tinzaparin sodium for thrombosis treatment and prevention during pregnancy Am J Obstet Gynecol 190, 495–501.

    Article  PubMed  CAS  Google Scholar 

  81. Gynaecologists, R.C.o.O.a. Thromboembolic Disease in Pregnancy and the Puerperium: Acute Management. Guideline No. 28 Update. London: RCOG Press; 2007.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA

    Shaker A. Mousa

  2. College of Medicine, King Abdul-Aziz University, Jeddah, Saudi Arabia

    Mohamad H. Qari

Authors
  1. Shaker A. Mousa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohamad H. Qari
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. , Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sc, Discovery Drive One, Rensselaer, 12144, New York, USA

    Shaker A. Mousa

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Mousa, S.A., Qari, M.H. (2010). Diagnosis and Management of Sickle Cell Disorders. In: Mousa, S. (eds) Anticoagulants, Antiplatelets, and Thrombolytics. Methods in Molecular Biology, vol 663. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-803-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-803-4_13

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-802-7

  • Online ISBN: 978-1-60761-803-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation